Revealing the Clinical Outcomes of SB-121 in Autism Spectrum Disorder
Time: 2:30 pm
day: Conference Day Two Track B PM 1
Details:
- Phase Ib Data in Patients with Autism Spectrum Disorder
- Clinical Evidence from Objective and Subjective Measures of Behavior
- Pre-clinical to Clinical Mechanism of Action Data
